Latest filings (excl ownership)
6-K
BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
18 Mar 24
6-K
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
6 Mar 24
6-K
Current report (foreign)
10 Jan 24
6-K
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
19 Dec 23
6-K
Current report (foreign)
20 Nov 23
6-K
BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights
15 Nov 23
6-K
Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction
2 Nov 23
6-K
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Depression
16 Oct 23
6-K
BrainsWay Broadens Access to Deep TMS™ for U.S. Military Service Members Through Expanded Partnership with Katie’s Way Plus
20 Sep 23
6-K
10 Deep TMS™ Systems to be Installed in 2023 Alone
5 Sep 23
6-K
Current report (foreign)
23 Aug 23
6-K
BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights
9 Aug 23
6-K
Current report (foreign)
11 Jul 23
6-K
Current report (foreign)
21 Jun 23
6-K
BrainsWay Announces Appointment of Ido Marom as CFO
23 May 23
6-K
BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
17 May 23
20-F
2022 FY
Annual report (foreign)
27 Mar 23
6-K
Current report (foreign)
20 Mar 23
6-K
BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights
15 Mar 23
6-K
Notice of Annual General Meeting of Shareholders
13 Feb 23
6-K
BrainsWay Announces Appointment of Ami Boehm as New Chairman
13 Feb 23
6-K
BrainsWay Announces Appointment of Hadar Levy as CEO
13 Feb 23
6-K
BrainsWay Appoints Ami Boehm as Board Member
12 Jan 23
6-K
Current report (foreign)
10 Jan 23
6-K
BrainsWay Reports Open Market Stock Purchases by Two Board Members
28 Nov 22
6-K
BrainsWay Reports Third Quarter 2022 Financial Results and Operational Highlights
16 Nov 22
6-K
Current report (foreign)
14 Sep 22
6-K
BrainsWay Receives New FDA Clearance for Treating Depression and Anxious Depression
29 Aug 22
6-K
BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights
10 Aug 22
6-K
BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression
28 Jun 22
6-K
BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights
11 May 22
20-F
2021 FY
Annual report (foreign)
12 Apr 22
6-K
BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights
9 Mar 22
6-K
Current report (foreign)
31 Jan 22
6-K
Current report (foreign)
23 Dec 21
6-K
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects
9 Dec 21
6-K
Current report (foreign)
17 Nov 21
6-K
BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights
17 Nov 21
EFFECT
Notice of effectiveness
12 Oct 21
CORRESP
Correspondence with SEC
6 Oct 21
Latest ownership filings
SC 13G/A
HIRSCHMAN ORIN
21 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
HIRSCHMAN ORIN
7 Feb 24
SC 13G
HIRSCHMAN ORIN
14 Jun 23
SC 13G/A
Phoenix Holdings Ltd.
3 Apr 23
SC 13G/A
Phoenix Holdings Ltd.
14 Feb 23
SC 13G/A
MASTERS CAPITAL MANAGEMENT LLC
14 Feb 23
SC 13G/A
Cowen Financial Products LLC
18 Jan 23
SC 13G
Zacut David
30 Nov 22
SC 13G
Hagai Avner
30 Nov 22
SC 13G/A
Cowen Financial Products LLC
30 Mar 22
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 22
SC 13G
MASTERS CAPITAL MANAGEMENT LLC
11 Feb 22
SC 13G/A
Phoenix Holdings Ltd.
7 Feb 22
SC 13G/A
Cowen Financial Products LLC
20 Jan 22
SC 13G/A
Cowen Financial Products LLC
19 Jan 22
SC 13G/A
RTW INVESTMENTS, LP
12 Feb 21
SC 13G/A
Phoenix Holdings Ltd.
11 Feb 21
SC 13G
Cowen Financial Products LLC
26 Jan 21
SC 13G/A
Brainsway Ltd.
18 Feb 20
SC 13G/A
Brainsway Ltd.
14 Feb 20
SC 13G
Brainsway Ltd.
30 Jan 20
SC 13G
Brainsway Ltd.
19 Aug 19
SC 13G
Brainsway Ltd.
6 May 19